Spine BioPharma, Inc., a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc ...

Canaccord analyst Kingsley Crane raised the firm’s price target on CrowdStrike (CRWD) to $420 from $370 and keeps a Buy rating on the shares.

Canaccord raised the firm’s price target on Okta (OKTA) to $100 from $94 and keeps a Hold rating on the shares. The firm said they reported ...

Cardinal Energy Ltd. (TSX: CJ) ("Cardinal" or the "Company") is pleased to announce that it has completed its previously ...

TTEC (NASDAQ:TTEC – Free Report) had its target price reduced by Canaccord Genuity Group from $4.50 to $3.50 in a research ...

The looming end to Australia’s $40bn hybrid securities market represents a big opportunity for stockbroking veteran Geoff ...

Clover Health Investments (NASDAQ:CLOV – Free Report) had its target price raised by Canaccord Genuity Group from $4.20 to $4.50 in a research report report published on Monday morning,Benzinga ...

Find insight on lithium, lumber, the impact of tariffs and more in the latest Market Talks covering Basic Materials.

NuScale Power Corporation (NYSE: SMR) Q4 2024 Earnings Call Transcript March 3, 2025 NuScale Power Corporation beats earnings expectations. Reported EPS is $0.6, expectations were $-0.11.

CAMBRIDGE, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the ...

Shed, a telehealth clinic specializing in weight loss, is excited to announce the launch of Low-Dose Naltrexone (LDN), an innovative, therapeutic solution for individuals managing chronic pain, ...

Cryptocurrencies surge after President Trump says tokens to be included in strategic reserve ( FT) Intel shares rise after ...